| RS1553266052 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553266098 |
LMNA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553266166 |
SNX27
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1553266260 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553266337 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Charcot-Marie-Tooth disease type 2 |
| RS1553266433 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553266474 |
SDHC
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1553266537 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553266671 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553266871 |
LAMC2
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS1553267007 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553267060 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553267345 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553267356 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553267499 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553267554 |
LAMC2
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa |
| RS1553267638 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553267679 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553267870 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553267882 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553267885 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553268427 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553268434 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553268435 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553268562 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553268563 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Usher syndrome type 2A |
| RS1553268582 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553268594 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553268799 |
PSEN2
|
Health Risk |
Likely pathogenic |
Alzheimer disease 4, Alzheimer disease 4 |
| RS1553270468 |
ZBTB18
|
Health Risk |
Likely pathogenic |
— |
| RS1553270470 |
ZBTB18
|
Health Risk |
Pathogenic |
ZBTB18-related disorder, ZBTB18-related disorder |
| RS1553270522 |
ZBTB18
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553270599 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Marfanoid habitus and intellectual disability, Intellectual disability |
| RS1553270611 |
ZBTB18
|
Health Risk |
Pathogenic |
— |
| RS1553270631 |
ZBTB18
|
Health Risk |
Likely pathogenic |
— |
| RS1553270634 |
ZBTB18
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 22 |
| RS1553270640 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS1553270954 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553270960 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553271001 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553271002 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553271837 |
EDARADD
|
Health Risk |
Likely pathogenic |
— |
| RS1553272035 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 39 |
| RS1553272176 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553272201 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553272873 |
CAMTA1
|
Health Risk |
Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS1553273280 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 39 |
| RS1553273330 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553273412 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553273421 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553273525 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
— |
| RS1553273733 |
CFH
|
Health Risk |
Pathogenic |
Hemolytic uremic syndrome, atypical |
| RS1553274382 |
RAB3GAP2
|
Health Risk |
Pathogenic |
— |
| RS1553274424 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553274435 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553274448 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553274531 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1553275034 |
LAMB3
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1A, Amelogenesis imperfecta type 1A |
| RS1553275070 |
LAMB3
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1A, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553275192 |
PKP1
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex due to plakophilin deficiency, Epidermolysis bullosa simplex due to plakophilin deficiency |
| RS1553275195 |
LAMB3
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1A, Amelogenesis imperfecta type 1A |
| RS1553275219 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553275644 |
RAB3GAP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553275687 |
RAB3GAP2
|
Health Risk |
Pathogenic |
Warburg micro syndrome 2, Warburg micro syndrome 2 |
| RS1553276110 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553276216 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553276268 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553276430 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553276474 |
COQ8A
|
Health Risk |
Likely pathogenic |
— |
| RS1553276488 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553276966 |
COQ8A
|
Health Risk |
Likely pathogenic |
— |
| RS1553277072 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS1553277267 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553277432 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553277483 |
CDC73
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553277591 |
PLXNA2
|
Health Risk |
Likely pathogenic |
atypical cerebral palsy, atypical cerebral palsy |
| RS1553277686 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553277702 |
LAMB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS1553277866 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553278569 |
RAB3GAP2
|
Health Risk |
Pathogenic |
Warburg micro syndrome 2, Warburg micro syndrome 2 |
| RS1553278841 |
CDC73
|
Health Risk |
Pathogenic |
— |
| RS1553278844 |
CDC73
|
Health Risk |
Pathogenic/Likely pathogenic |
Parathyroid carcinoma, Hereditary cancer-predisposing syndrome |
| RS1553279044 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553279073 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553279085 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1553279088 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1553279294 |
TNNT2
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1553280067 |
CAMTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS1553280621 |
COQ8A
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS1553281291 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1553281318 |
COQ8A
|
Health Risk |
Pathogenic |
7 conditions, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS1553281319 |
TNNT2
|
Health Risk |
Likely pathogenic |
— |
| RS1553281335 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS1553281890 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553281924 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1553282089 |
HNRNPU
|
Health Risk |
Likely pathogenic |
— |
| RS1553282235 |
HNRNPU
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553282372 |
HNRNPU
|
Health Risk |
Likely pathogenic |
— |
| RS1553282385 |
HNRNPU
|
Health Risk |
Pathogenic |
— |
| RS1553282390 |
HNRNPU
|
Health Risk |
Pathogenic |
— |